Divi's Laboratories announced a robust financial performance for the March quarter of FY25, with a 25.6% YoY surge in standalone net profit, reaching Rs 667 crore. Revenue from operations also climbed by 12.26% to Rs 2,536 crore. The company's board declared a dividend of Rs 30 per share and (...)
Site référencé: The Economic Times
The Economic Times
Positive Breakout : These 6 stocks cross above their 200 DMAs
19/05/2025
Vodafone Idea shares dive 12% as SC rejects $5B dues waiver
19/05/2025
Wall Street futures, dollar ease in wake of credit blow
19/05/2025
Nifty likely to advance towards 25,200-25,800 : Analysts
19/05/2025
Why are two-thirds of recent IPOs trading below their listing price ?
19/05/2025
Shapoorji Pallonji asks RBI for three-year relief on Sterling Capital rules
19/05/2025
